Conflict of Interest? No Problem

Print Friendly, PDF & Email

One hopes that when defining the clinical practice guidelines for a given disease and the prescribing practices for a particular drug,  the physicians on the panel who determine these things would have no vested interest in suggesting one medication or another. To the contrary, a recent study on diabetes and cholesterol prescribing recommendations found that this is most certainly not the case. Fully 52% of the panel members and 50% of the panel chairs convened to determine diabetes and cholesterol care, had a financial conflict of interest with drug companies. Though some disclosed their ties to drug companies, many others did not. Moreover, many of these panels have no disclosure rules. Beyond simple disclosure, a good first step, I think we all agree that those in charge of deciding the course of our care, should have no financial ties to the industry.

Related links:

Conflicts of Interest: Study

Medical Panels Are Rife With Financial Conflicts

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Previous Story

Unite Walking Uteri: Repair the Economic Moral Fabric, One Woman at a Time

Next Story

The Match Game Of Healthcare That Works (Part II)

Latest from Research & Commentary